EPS

Zacks Small Cap Research – RERE 1Q25 Earnings Review: EPS Strength Beneath the Surface; Rising Trade-In Activity Increasingly Driving Growth – Go Health Pro

by

By Michael Kim NYSE:RERE READ THE FULL RERE RESEARCH REPORT Pre-market open on 5/20/25, ATRenew (NYSE:RERE) reported 1Q25 earnings results. On a GAAP basis, RERE reported net income of $5.9 million for 1Q25, or $0.02 per ADS. That said, excluding non-cash share-based compensation and intangible assets amortization expenses, adjusted EPS came in at $0.04, or … Read more

Zacks Small Cap Research – DEFT: 1Q25 Earnings Review: Adjusted EPS Miss on Higher Expenses; Raising on EPS Estimates/Price Target on Accelerating Momentum across the Franchise – Go Health Pro

by

By Michael Kim NASDAQ:DEFT READ THE FULL DEFT RESEARCH REPORT Pre-market open on 5/14/25, DeFi Technologies (NASDAQ:DEFT) reported 1Q25 earnings results. On an IFRS basis, DEFT reported net income per share of $0.08, or meaningfully above our $0.04 estimate. While mark-to-market noise makes actual vs. estimate analysis a bit more challenging, we note core revenue … Read more

Zacks Small Cap Research – CCLD: 1Q25 Earnings Review – Slight EPS Miss on Higher Expenses; Multi-Layered Growth Story – Go Health Pro

by

By Michael Kim NASDAQ:CCLD READ THE FULL CCLD RESEARCH REPORT Pre-market open on 5/6/25, CareCloud (NASDAQ:CCLD) reported 1Q25 earnings results. For the quarter, CCLD reported GAAP net income of $1.9 million – the company’s fourth consecutive positive net income quarter, and a reversal from a net loss of $0.2 million for the year-ago quarter. After … Read more

Zacks Small Cap Research – RERE: 4Q24 Earnings Review: EPS as Expected; Investing for Growth to Keep Pace with Accelerating Demand – Go Health Pro

by

By Michael Kim NYSE:RERE READ THE FULL RERE RESEARCH REPORT Pre-market open on 3/11/25, ATRenew (NYSE:RERE) reported 4Q24 earnings results. On a GAAP basis, RERE reported net income of $10.6 million for 4Q24, or $0.04 per ADS. That said, excluding non-cash share-based compensation and intangible assets amortization expenses, adjusted EPS came in at $0.07, or … Read more

Zacks Small Cap Research – QSG: F1Q25 Earnings Review: EPS Miss on Lower Revenues; Silver Transition Gaining Momentum – Go Health Pro

by

By Michael Kim NASDAQ:QSG READ THE FULL QSG RESEARCH REPORT Pre-market open on 11/27/24, QuantaSing (NASDAQ:QSG) reported F1Q25 (Sep) earnings results. On a GAAP basis, QSG reported net income of $11.5 million for F1Q25, or $0.21 per ADS. That said, excluding share-based compensation expenses, adjusted EPS came in at $0.23, or below our estimate of … Read more